333 related articles for article (PubMed ID: 19015650)
41. Quantitative kinetics of [124I]FIAU in cat and man.
Jacobs A; Bräunlich I; Graf R; Lercher M; Sakaki T; Voges J; Hesselmann V; Brandau W; Wienhard K; Heiss WD
J Nucl Med; 2001 Mar; 42(3):467-75. PubMed ID: 11337525
[TBL] [Abstract][Full Text] [Related]
42. Quantitation of pulmonary transgene expression with PET imaging.
Richard JC; Zhou Z; Chen DL; Mintun MA; Piwnica-Worms D; Factor P; Ponde DE; Schuster DP
J Nucl Med; 2004 Apr; 45(4):644-54. PubMed ID: 15073262
[TBL] [Abstract][Full Text] [Related]
43. Normal brain cells contribute to the bystander effect in suicide gene therapy of malignant glioma.
Miletic H; Fischer YH; Giroglou T; Rueger MA; Winkeler A; Li H; Himmelreich U; Stenzel W; Jacobs AH; von Laer D
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6761-8. PubMed ID: 18006778
[TBL] [Abstract][Full Text] [Related]
44. Thymidine Kinase PET Reporter Gene Imaging of Cancer Cells In Vivo.
McCracken MN
Methods Mol Biol; 2018; 1790():137-151. PubMed ID: 29858789
[TBL] [Abstract][Full Text] [Related]
45. A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme.
Rainov NG
Hum Gene Ther; 2000 Nov; 11(17):2389-401. PubMed ID: 11096443
[TBL] [Abstract][Full Text] [Related]
46. PET Reporter Gene Imaging and Ganciclovir-Mediated Ablation of Chimeric Antigen Receptor T Cells in Solid Tumors.
Murty S; Labanieh L; Murty T; Gowrishankar G; Haywood T; Alam IS; Beinat C; Robinson E; Aalipour A; Klysz DD; Cochran JR; Majzner RG; Mackall CL; Gambhir SS
Cancer Res; 2020 Nov; 80(21):4731-4740. PubMed ID: 32958548
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of F-18-labeled 5-iodocytidine (18F-FIAC) as a new potential positron emission tomography probe for herpes simplex virus type 1 thymidine kinase imaging.
Chan PC; Wu CY; Chang WY; Chang WT; Alauddin M; Liu RS; Lin WJ; Chen FD; Chen CL; Wang HE
Nucl Med Biol; 2011 Oct; 38(7):987-95. PubMed ID: 21982570
[TBL] [Abstract][Full Text] [Related]
48. Quantitation of cell number by a positron emission tomography reporter gene strategy.
Su H; Forbes A; Gambhir SS; Braun J
Mol Imaging Biol; 2004; 6(3):139-48. PubMed ID: 15193248
[TBL] [Abstract][Full Text] [Related]
49. Comparison of [18F]FHBG and [14C]FIAU for imaging of HSV1-tk reporter gene expression: adenoviral infection vs stable transfection.
Min JJ; Iyer M; Gambhir SS
Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1547-60. PubMed ID: 14579096
[TBL] [Abstract][Full Text] [Related]
50. Multitracer positron emission tomographic imaging of exogenous gene expression mediated by a universal herpes simplex virus 1 amplicon vector.
Kummer C; Winkeler A; Dittmar C; Bauer B; Rueger MA; Rueckriem B; Heneka MT; Vollmar S; Wienhard K; Fraefel C; Heiss WD; Jacobs AH
Mol Imaging; 2007; 6(3):181-92. PubMed ID: 17532884
[TBL] [Abstract][Full Text] [Related]
51. MicroPET imaging of prostate cancer in LNCAP-SR39TK-GFP mouse xenografts.
Yang H; Berger F; Tran C; Gambhir SS; Sawyers CL
Prostate; 2003 Apr; 55(1):39-47. PubMed ID: 12640659
[TBL] [Abstract][Full Text] [Related]
52. 5-[18F]Fluoroalkyl pyrimidine nucleosides: probes for positron emission tomography imaging of herpes simplex virus type 1 thymidine kinase gene expression.
Chacko AM; Blankemeyer E; Lieberman BP; Qu W; Kung HF
Nucl Med Biol; 2009 Jan; 36(1):29-38. PubMed ID: 19181266
[TBL] [Abstract][Full Text] [Related]
53. Antiglioma immunological memory in response to conditional cytotoxic/immune-stimulatory gene therapy: humoral and cellular immunity lead to tumor regression.
Ghulam Muhammad AK; Candolfi M; King GD; Yagiz K; Foulad D; Mineharu Y; Kroeger KM; Treuer KA; Nichols WS; Sanderson NS; Yang J; Khayznikov M; Van Rooijen N; Lowenstein PR; Castro MG
Clin Cancer Res; 2009 Oct; 15(19):6113-27. PubMed ID: 19789315
[TBL] [Abstract][Full Text] [Related]
54. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography.
Tjuvajev JG; Avril N; Oku T; Sasajima T; Miyagawa T; Joshi R; Safer M; Beattie B; DiResta G; Daghighian F; Augensen F; Koutcher J; Zweit J; Humm J; Larson SM; Finn R; Blasberg R
Cancer Res; 1998 Oct; 58(19):4333-41. PubMed ID: 9766661
[TBL] [Abstract][Full Text] [Related]
55. Application of bioluminescence imaging to therapeutic intervention of herpes simplex virus type I - Thymidine kinase/ganciclovir in glioma.
Jang SJ; Kang JH; Kim KI; Lee TS; Lee YJ; Lee KC; Woo KS; Chung WS; Kwon HC; Ryu CJ; Choi TH; Choi CW; Lim SM; Cheon GJ
Cancer Lett; 2010 Nov; 297(1):84-90. PubMed ID: 20819721
[TBL] [Abstract][Full Text] [Related]
56. Imaging-guided gene therapy of experimental gliomas.
Jacobs AH; Rueger MA; Winkeler A; Li H; Vollmar S; Waerzeggers Y; Rueckriem B; Kummer C; Dittmar C; Klein M; Heneka MT; Herrlinger U; Fraefel C; Graf R; Wienhard K; Heiss WD
Cancer Res; 2007 Feb; 67(4):1706-15. PubMed ID: 17308112
[TBL] [Abstract][Full Text] [Related]
57. Structure-guided engineering of human thymidine kinase 2 as a positron emission tomography reporter gene for enhanced phosphorylation of non-natural thymidine analog reporter probe.
Campbell DO; Yaghoubi SS; Su Y; Lee JT; Auerbach MS; Herschman H; Satyamurthy N; Czernin J; Lavie A; Radu CG
J Biol Chem; 2012 Jan; 287(1):446-454. PubMed ID: 22074768
[TBL] [Abstract][Full Text] [Related]
58. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
Wang HE; Yu HM; Liu RS; Lin M; Gelovani JG; Hwang JJ; Wei HJ; Deng WP
J Nucl Med; 2006 Jul; 47(7):1161-71. PubMed ID: 16818951
[TBL] [Abstract][Full Text] [Related]
59. Monitoring adenoviral DNA delivery, using a mutant herpes simplex virus type 1 thymidine kinase gene as a PET reporter gene.
Liang Q; Nguyen K; Satyamurthy N; Barrio JR; Phelps ME; Gambhir SS; Herschman HR
Gene Ther; 2002 Dec; 9(24):1659-66. PubMed ID: 12457279
[TBL] [Abstract][Full Text] [Related]
60. A phase I/II study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for recurrent glioblastoma. Study Group on Gene Therapy for Glioblastoma.
Klatzmann D; Valéry CA; Bensimon G; Marro B; Boyer O; Mokhtari K; Diquet B; Salzmann JL; Philippon J
Hum Gene Ther; 1998 Nov; 9(17):2595-604. PubMed ID: 9853526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
